# Koninklijke Philips N.V. NY Registry Shares (PHG) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Medical Devices & Supplies. Price $28.46, market value $27.8 billion.

## Valuation
- **P/E (trailing): 59.3×** (5-yr avg 18.7×, 3-yr avg 28.0×). Koninklijke Philips N.V. NY Registry Shares trades at 59.3× trailing earnings, well above its own five-year average of 18.7×: investors are paying up relative to the company's past. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 15.1×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.4×**. Each dollar of revenue is priced at 1.4×.
- **Price / book: 2.2×**. The shares trade at 2.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 9.6×**. Enterprise value is 9.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 6.5%**. Free cash flow equals 6.5% of the market value. Above 5% is generally attractive.
- **Earnings yield: 1.7%**. The inverse of the P/E: 1.7% of the price is earned each year.

## Profitability
- **Gross margin: 45.9%**. Koninklijke Philips N.V. NY Registry Shares keeps 45.9% of revenue after the direct cost of what it sells.
- **Operating margin: 9.9%**. 9.9% of revenue is left after running the business.
- **Net margin: 5.0%**. 5.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.2%**. 8.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 8.7%**. Return on all capital, debt included, is 8.7%.
- **Return on assets: 4.1%**. Each dollar of assets produces 4.1% of profit.

## Growth
- **Revenue growth (1 yr): -1.0%** (3-yr 0.0%/yr, 5-yr 0.6%/yr). Revenue fell 1.0% over the last year, against 0.6% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 224.0%** (5-yr -6.3%/yr). Earnings per share rose 224.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.64**. Debt is 0.64 times equity, moderate leverage.
- **Net debt / EBITDA: 1.4×**. It would take 1.4 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 5.6×**. Operating profit covers interest 5.6× over, a safe margin.
- **Current ratio: 1.32** (quick 1.32). Current assets cover the next year's liabilities 1.32 times.
- **Altman Z-score: 2.56**. A Z-score of 2.56 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 3.56%** ($1.01 per share, trailing). Koninklijke Philips N.V. NY Registry Shares yields 3.56%, an income-level yield.
- **Payout ratio: 37%**. 37% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): -11.8%/yr** (1-yr -6.5%). The dividend has not grown over five years.
- **Shareholder yield: 3.5%**. Dividends plus net buybacks return 3.5% of the market value a year.

## Price and momentum
- **Total return (1 yr): 4.9%** (YTD 5.9%, 3-mo 5.2%). The shares are up 4.9% over twelve months including dividends.
- **From 52-week high: -14.9%** (20.5% above the low). Trading 15% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 71**. An RSI of 71 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.80** (volatility 28%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PHG · Page: https://foliofundamentals.com/stocks/phg

Not investment advice.